Patterson-UTI supplements proxy with DCF ranges; merger lawsuit filed

PATTERSON UTI ENERGY INC

Patterson-UTI voluntarily supplements proxy to address stockholder lawsuit alleging disclosure deficiencies in merger voting materials.
Goldman Sachs DCF analysis: Patterson-UTI standalone PV $16.90-$28.77/share; NexTier $12.42-$20.91/share; combined $18.14-$30.80/share.
Net debt used: Patterson-UTI ~$670M, NexTier ~$204M, pro forma combined ~$874M; share counts of 213.4M, 236.3M, 391M respectively.
Special shareholder meetings remain scheduled for August 30, 2023.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.